We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture and influences all aspects of our approach to advancing cutting-edge technologies. Building on our core beliefs, our mission-focused behaviors help us define and shape our culture; drive performance and innovation; inform development and growth; and attract, energize, and retain the right talent. By championing mission-dedication, innovation, performance, and integrity, we are united by our passion for making a difference and committed to pushing ideas as far and as fast as possible. Our global footprint spans over 20 countries, including our global headquarters in Princeton, NJ and international headquarters in Marlow, UK. Additional international office locations include Australia, Canada, France, Japan, Germany, Italy, The Netherlands, and Spain. More information about Amicus and our career opportunities can be found at www.amicusrx.com.
View Top Employees from Amicus TherapeuticsWebsite | http://www.amicusrx.com |
Ticker | FOLD |
Revenue | $260 million |
Funding | $475 million |
Employees | 663 (663 on RocketReach) |
Founded | 2002 |
Address | 47 Hullfish Street, Princeton, New Jersey 08542, US |
Phone | (609) 662-2000 |
Fax | (609) 662-2001 |
Technologies |
JavaScript,
HTML,
PHP
+81 more
(view full list)
|
Industry | Pharmaceuticals, Biotechnology Research, Biotechnology, Healthcare, Science and Engineering, Health Care, Pharmaceutical |
Web Rank | 3 Million |
Keywords | Amicus Therapeutics, Amicus Galafold, Amicus, Left Ventricular Mass Index Migalastat Egfr, Galafoldtm |
Competitors | Acceleron Pharma, Pharmacyclics, an AbbVie Company, Portola Pharmaceuticals, Relypsa, Sage Therapeutics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Amicus Therapeutics employee's phone or email?
The Amicus Therapeutics annual revenue was $260 million in 2024.
Daphne Quimi is the CFO of Amicus Therapeutics.
663 people are employed at Amicus Therapeutics.
Amicus Therapeutics is based in Princeton, New Jersey.
The NAICS codes for Amicus Therapeutics are [32541, 3254, 32, 325].
The SIC codes for Amicus Therapeutics are [28, 283].